{"id":1251,"date":"2022-03-07T15:30:00","date_gmt":"2022-03-07T07:30:00","guid":{"rendered":"https:\/\/aprea.asia\/?post_type=knowledge-hub&p=1251"},"modified":"2025-03-18T15:33:20","modified_gmt":"2025-03-18T07:33:20","slug":"cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects","status":"publish","type":"knowledge-hub","link":"https:\/\/www.aprea.asia\/ja\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/","title":{"rendered":"Cushman & Wakefield – Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects"},"content":{"rendered":"

Bolstered by increasing biotech investments and accelerating healthcare research, the biomedical sciences (BMS) industry has experienced strong growth in recent years, further reinforcing Singapore\u2019s position as a leading biomedical science hub at the heart of Asia.<\/p>\n\n\n\n

This report provides an overview of Singapore\u2019s BMS industry and its real estate requirements with the focus on key drivers for the industry, demand, future supply and rentals of life science properties.<\/p>","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":true},"kh_category":[14],"class_list":["post-1251","knowledge-hub","type-knowledge-hub","status-publish","hentry","kh_category-asset-management-center"],"acf":[],"yoast_head":"\nCushman & Wakefield - Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects - Asia Pacific Real Assets Association<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aprea.asia\/ja\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cushman & Wakefield - Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects - Asia Pacific Real Assets Association\" \/>\n<meta property=\"og:description\" content=\"Bolstered by increasing biotech investments and accelerating healthcare research, the biomedical sciences (BMS) industry has experienced strong growth in recent years, further reinforcing Singapore\u2019s position as a leading biomedical science hub at the heart of Asia. This report provides an overview of Singapore\u2019s BMS industry and its real estate requirements with the focus on key drivers for the industry, demand, future supply and rentals of life science properties.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aprea.asia\/ja\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/\" \/>\n<meta property=\"og:site_name\" content=\"Asia Pacific Real Assets Association\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-18T07:33:20+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/\",\"url\":\"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/\",\"name\":\"Cushman & Wakefield - Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects - Asia Pacific Real Assets Association\",\"isPartOf\":{\"@id\":\"https:\/\/www.aprea.asia\/#website\"},\"datePublished\":\"2022-03-07T07:30:00+00:00\",\"dateModified\":\"2025-03-18T07:33:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.aprea.asia\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Knowledge Hub\",\"item\":\"https:\/\/www.aprea.asia\/knowledge-hub\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cushman & Wakefield – Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.aprea.asia\/#website\",\"url\":\"https:\/\/www.aprea.asia\/\",\"name\":\"Asia Pacific Real Assets Association\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.aprea.asia\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cushman & Wakefield - Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects - Asia Pacific Real Assets Association","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aprea.asia\/ja\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/","og_locale":"ja_JP","og_type":"article","og_title":"Cushman & Wakefield - Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects - Asia Pacific Real Assets Association","og_description":"Bolstered by increasing biotech investments and accelerating healthcare research, the biomedical sciences (BMS) industry has experienced strong growth in recent years, further reinforcing Singapore\u2019s position as a leading biomedical science hub at the heart of Asia. This report provides an overview of Singapore\u2019s BMS industry and its real estate requirements with the focus on key drivers for the industry, demand, future supply and rentals of life science properties.","og_url":"https:\/\/www.aprea.asia\/ja\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/","og_site_name":"Asia Pacific Real Assets Association","article_modified_time":"2025-03-18T07:33:20+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/","url":"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/","name":"Cushman & Wakefield - Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects - Asia Pacific Real Assets Association","isPartOf":{"@id":"https:\/\/www.aprea.asia\/#website"},"datePublished":"2022-03-07T07:30:00+00:00","dateModified":"2025-03-18T07:33:20+00:00","breadcrumb":{"@id":"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.aprea.asia\/knowledge-hub\/cushman-wakefield-biomedical-sciences-a-niche-asset-class-with-strong-growth-prospects\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aprea.asia\/"},{"@type":"ListItem","position":2,"name":"Knowledge Hub","item":"https:\/\/www.aprea.asia\/knowledge-hub\/"},{"@type":"ListItem","position":3,"name":"Cushman & Wakefield – Biomedical Sciences: A Niche Asset Class With Strong Growth Prospects"}]},{"@type":"WebSite","@id":"https:\/\/www.aprea.asia\/#website","url":"https:\/\/www.aprea.asia\/","name":"\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u4e0d\u52d5\u7523\u5354\u4f1a","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aprea.asia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"}]}},"_links":{"self":[{"href":"https:\/\/www.aprea.asia\/ja\/wp-json\/wp\/v2\/knowledge-hub\/1251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aprea.asia\/ja\/wp-json\/wp\/v2\/knowledge-hub"}],"about":[{"href":"https:\/\/www.aprea.asia\/ja\/wp-json\/wp\/v2\/types\/knowledge-hub"}],"wp:attachment":[{"href":"https:\/\/www.aprea.asia\/ja\/wp-json\/wp\/v2\/media?parent=1251"}],"wp:term":[{"taxonomy":"kh_category","embeddable":true,"href":"https:\/\/www.aprea.asia\/ja\/wp-json\/wp\/v2\/kh_category?post=1251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}